Health stocks ended Friday on a generally upbeat note. The Nasdaq biotechnology index closed up 1.3%, and the Amex pharma index finished up 0.6% at 305.34.Genentech ( DNA) rose 1.4% to $96 Friday following a late-Thursday announcement that the biotech company has formed a team to assess Roche's $89-a-share buyout bid. Genentech stated it's not obligated to agree to a deal with its majority shareholder. A number of Wall Street upgrades and positive notes sent several stocks in the sector higher. BioMarin Pharmaceutical ( BMRN - Get Report) rose 1.9% to $31.49 on a UBS upgrade to buy from neutral. BioSphere Medical ( BSMD) rose 2.2% to $3.65 on an upgrade by Piper Jaffray from neutral to buy. Shares of medical equipment company RTI Biologics ( RTIX - Get Report) rose 5.3% to $8.41 on an upgrade by Roth Capital from hold to buy. And Alexion Pharmaceuticals ( ALXN - Get Report) climbed 6.1% to $80.98 after Collins Stewart initiated coverage of the stock with a buy rating.
More from Investing
Dow Futures Edge Higher, Global Stocks Gain Despite Elusive Trade Deal Certainty
U.S. equity futures edged higher Friday, setting up the chance to snap a three-day losing streak on Wall Street, as investors continue to fixate on the fate of trade talks between Washington and Beijing and the strength of the American consumer heading into the holiday season.
Live Nation Shares Slip on Probe of 'Unfair and Deceptive Practices'
Congressional committee investigation targets online ticket brokers including Live Nation, eBay's Stub Hub and Major League Baseball's Tickets.com.
Mondelez Cheese Nips Recall Hits Snack Giant's Stock Price
Mondelez Global's stock price took a hit Thursday after the snack giant announced a limited recall of Cheese Nips.